ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion

Mike R. Wilson(Michigan State University), Jake J. Reske(Michigan State University), Jeanne Holladay(Michigan State University), Genna E. Wilber(Michigan State University), Mary Rhodes(Van Andel Institute), Julie Koeman(Van Andel Institute), Marie Adams(Van Andel Institute), Ben K. Johnson(Van Andel Institute), Ren‐Wei Su(Michigan State University), Niraj Joshi(Michigan State University), Amanda L. Patterson(Michigan State University), Hui Shen(Van Andel Institute), Richard E. Leach(Spectrum Health), Jose M. Teixeira(Spectrum Health), Asgerally T. Fazleabas(Spectrum Health), Ronald L. Chandler(Van Andel Institute)
Nature Communications
August 7, 2019
Cited by 136Open Access
Full Text

Abstract

ARID1A and PI3-Kinase (PI3K) pathway alterations are common in neoplasms originating from the uterine endometrium. Here we show that monoallelic loss of ARID1A in the mouse endometrial epithelium is sufficient for vaginal bleeding when combined with PI3K activation. Sorted mutant epithelial cells display gene expression and promoter chromatin signatures associated with epithelial-to-mesenchymal transition (EMT). We further show that ARID1A is bound to promoters with open chromatin, but ARID1A loss leads to increased promoter chromatin accessibility and the expression of EMT genes. PI3K activation partially rescues the mesenchymal phenotypes driven by ARID1A loss through antagonism of ARID1A target gene expression, resulting in partial EMT and invasion. We propose that ARID1A normally maintains endometrial epithelial cell identity by repressing mesenchymal cell fates, and that coexistent ARID1A and PI3K mutations promote epithelial transdifferentiation and collective invasion. Broadly, our findings support a role for collective epithelial invasion in the spread of abnormal endometrial tissue.


Related Papers